Clorox Reports 18 Percent EPS Growth in Q2; Raises Fiscal Year 2016 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Clorox (CLX) Proves Conservative on Initial FY16 Guidance - UBS Raises PT to $110
February 5, 2016 9:49 AM ESTUBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $110.00 (from $105.00), following the company's 2Q earnings report. CLX reported $1.14 in EPS, beating consensus estimates of $1.05. This outperformance was driven largely by +210 bps in GM expansion. CLX did not raise FY16... More
Clorox (CLX) Tops Q2 EPS by 9c; Boosts Outlook Modestly
February 4, 2016 6:33 AM ESTClorox (NYSE: CLX) reported Q2 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.35 billion.
GUIDANCE:
Clorox sees FY2016 EPS of $4.75-$4.90, versus prior guidance of $4.68-$4.83 and the... More
